In Brief: National uniformity
This article was originally published in The Tan Sheet
Executive Summary
National uniformity: Support for Senate FDA reform legislation provision establishing national uniformity for OTC drugs and cosmetics is urged by the Nonprescription Drug Manufacturers Association, Cosmetic, Toiletry & Fragrance Association and other groups in July 14 and July 15 letters to Senate members. Groups including the Center for Science in the Public Interest, Natural Resources Defense Council and Environmental Defense Fund object to the provision and are working to have it removed from the bill. The Senate FDA reform bill (S 830) is expected to be considered on the Senate floor July 22-23 pending a time agreement by Senate leadership...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning